Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Viveon Health Acquisition Corp. does not have significant operations and was formed to effect a merger or similar business combination in the healthcare sector. It has announced definitive agreements to merge with Clearday, an innovative longevity technology company focused on senior care using AI-driven and robotic companion platforms. The merger aims to accelerate Clearday’s market entry but had not closed as of July 2024. Previously attempted a merger with Suneva Medical that did not close. No clinical results or pipeline exist for this entity itself. As a SPAC, its value lies in its ability to bring private companies public via mergers. The company’s stock was last traded at $11.00 on Jan 22, 2025 and then marked inactive. Key investors include Meteora Capital LLC.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Viveon Health Acquisition Corp..